Results 91 to 100 of about 38,493 (164)
Interim Effectiveness Estimates of 2023 Southern Hemisphere Influenza Vaccines in Preventing Influenza-Associated Hospitalizations - REVELAC-i Network, March-July 2023. [PDF]
MMWR Morb Mortal Wkly Rep, 2023 Fowlkes AL, Nogareda F, Regan A, Loayza S, Mancio JM, Duca LM, Couto P, Leite J, Rodriguez A, Salas D, Azziz-Baumgartner E, REVELAC–i Network. +11 moreeuropepmc +1 more sourceLeer a Silva a contrapelo: de sobremesa como novela tropical
Antípoda: Revista de Antropología y Arqueología, 2012 Fernández' civilizatory fantasy in J.A. Silva's De Sobremesa provides a position from which to re-read discourses about space and place written by elite Colombian geographers and ethnographers. From a vantage point infused in parody, this fantasy deploys Felipe Martínez Pinzóndoaj Randomized double-blind clinical trial evaluating the effectiveness and safety of secondary prophylaxis with oral vancomycin versus placebo in the prevention of recurrence of <i>clostridioides difficile</i> infection in patients receiving systemic antibiotic therapy (PREVAN trial). [PDF]
JAC Antimicrob ResistSan-Juan R, Origüen J, Fernández-Ruiz M, Campion K, Silva JT, López-Medrano F, Villa J, Díaz-Pollan B, Callejas-Díaz A, Candela G, Boan J, Aparicio-Minguijon E, Asin MAP, Rodriguez-Goncer I, Martín-Arriscado C, Ferrari JM, Aguado JM. +16 moreeuropepmc +1 more sourcePredictive validity of the Obsessive-Compulsive Inventory-4 and Florida Obsessive-Compulsive Inventory-II severity scale. [PDF]
J Psychiatr ResStorch EA, McCarty RJ, Zehavi M, Ahmad M, Cruz VZ, Berrones D, Muñoz JS, Obando D, Rodriguez Barajas S, Frederick RM, Anderberg JL, Moore HC, Ochoa-Panaifo ME, Martinez Mallen MC, Onyeka OC, Wiese AD, Sagarnaga MN, McGuire JF, Ferrão YA, Latin American Trans-Ancestry INitiative for OCD genomics (LATINO), Brazilian Obsessive-Compulsive Spectrum Disorder Working Group (GTTOC), Goodman WK, Crowley JJ. +22 moreeuropepmc +1 more sourceLong-term outcomes of the global tuberculosis and COVID-19 co-infection cohort. [PDF]
Eur Respir J, 2023 Global Tuberculosis Network and TB/COVID-19 Global Study Group, Casco N, Jorge AL, Palmero DJ, Alffenaar JW, Fox GJ, Ezz W, Cho JG, Denholm J, Skrahina A, Solodovnikova V, Arbex MA, Alves T, Rabahi MF, Pereira GR, Sales R, Silva DR, Saffie MM, Salinas NE, Miranda RC, Cisterna C, Concha C, Fernandez I, Villalón C, Vera CG, Tapia PG, Cancino V, Carbonell M, Cruz A, Muñoz E, Muñoz C, Navarro I, Pizarro R, Cristina Sánchez GP, Vergara Riquelme MS, Vilca E, Soto A, Flores X, Garavagno A, Bahamondes MH, Merino LM, Pradenas AM, Revillot ME, Rodriguez P, Salinas AS, Taiba C, Valdés JF, Subiabre JN, Ortega C, Palma S, Castillo PP, Pinto M, Bidegain FR, Venegas M, Yucra E, Li Y, Cruz A, Guelvez B, Victoria Plaza R, Tello Hoyos KY, Cardoso-Landivar J, Van Den Boom M, Andréjak C, Blanc FX, Dourmane S, Froissart A, Izadifar A, Rivière F, Schlemmer F, Manika K, Diallo BD, Hassane-Harouna S, Artiles N, Mejia LA, Gupta N, Ish P, Mishra G, Patel JM, Singla R, Udwadia ZF, Alladio F, Angeli F, Calcagno A, Centis R, Codecasa LR, De Lauretis A, Esposito SMR, Formenti B, Gaviraghi A, Giacomet V, Goletti D, Gualano G, Matteelli A, Migliori GB, Motta I, Palmieri F, Pontali E, Prestileo T, Riccardi N, Saderi L, Saporiti M, Sotgiu G, Spanevello A, Stochino C, Tadolini M, Torre A, Villa S, Visca D, Kurhasani X, Furjani M, Rasheed N, Danila E, Diktanas S, Ridaura RL, Luna López FL, Torrico MM, Rendon A, Akkerman OW, Chizaram O, Al-Abri S, Alyaquobi F, Althohli K, Aguirre S, Teixeira RC, De Egea V, Irala S, Medina A, Sequera G, Sosa N, Vázquez F, Llanos-Tejada FK, Manga S, Villanueva-Villegas R, Araujo D, Sales Marques RD, Socaci A, Barkanova O, Bogorodskaya M, Borisov S, Mariandyshev A, Kaluzhenina A, Vukicevic TA, Stosic M, Beh D, Ng D, Ong CWM, Solovic I, Dheda K, Gina P, Caminero JA, De Souza Galvão ML, Dominguez-Castellano A, García-García JM, Pinargote IM, Fernandez SQ, Sánchez-Montalvá A, Huguet ET, Murguiondo MZ, Bart PA, Mazza-Stalder J, D'Ambrosio L, Kamolwat P, Bakko F, Barnacle J, Bird S, Brown A, Chandran S, Killington K, Man K, Papineni P, Ritchie F, Tiberi S, Utjesanovic N, Zenner D, Hearn JL, Heysell S, Young L. +176 moreeuropepmc +1 more sourceEffectiveness and tolerability of dolutegravir/lamivudine for the treatment of HIV-1 infection in clinical practice. [PDF]
J Antimicrob Chemother, 2023 Suárez-García I, Alejos B, Hernando V, Viñuela L, Vera García M, Rial-Crestelo D, Pérez Elías MJ, Albendín Iglesias H, Peraire J, Tiraboschi J, Díaz A, Moreno S, Jarrín I, Cohort of the Spanish HIV/AIDS Research Network (CoRIS). +13 moreeuropepmc +1 more source
